Armistice Capital »

Bce shares owned by Armistice Capital

Quarter-by-quarter ownership of Bce (BCE) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Bce

Tip: Access up to 7 years of quarterly data

All positions including Bce held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bce by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $219k 5.7k 38.17

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Bce

Royal Bank of Canada
Bank Of Montreal
National Bank Of Canada /fi/
Vanguard Group
Bank of Nova Scotia
Caisse de depot et placement du Quebec
Deutsche Bank Aktiengesellschaft
TD Asset Management
Bank of America Corporation
Charles Schwab Investment Management
Scotia Capital
Jpmorgan Chase & Co
Connor, Clark & Lunn Investment Management
Goldman Sachs Group
Federated Investors

View all funds holding Bce